Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03002272 · ClinicalTrials.gov registry record

Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study

A clinical trial of Aortic Valve Replacement, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT03002272: Recruiting study of Aortic Valve Replacement, sponsored by Medstar Health Research Institute.

NCT03002272 is a study of Aortic Valve Replacement that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 100 participants, below the 385-participant average among 5 other Aortic Valve Replacement trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03002272, a study of Aortic Valve Replacement, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.

Primary Outcome

Mean aortic valve gradient ≥20 mm Hg Moderate-severe transvalvular aortic regurgitation

Conditions Studied

Interventions

  • DEVICE TAVR
  • DEVICE SAVR

Study Locations (1)

District of Columbia

  • Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-02-20
Est. Completion 2028-01
Medstar Health Research Institute

115 total trials

What NCT03002272 shows while recruiting

NCT03002272 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 385-participant average among 5 other Aortic Valve Replacement trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Aortic Valve Replacement appearing as the primary indexed condition, and to 2 interventions - of which TAVR is the first listed.

NCT03002272 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT03002272 about?

NCT03002272 is a clinical study titled "Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study". In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.

What is the current status of trial NCT03002272?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-02-20. Estimated completion is 2028-01.

What conditions does trial NCT03002272 study?

This clinical trial studies the following conditions: Aortic Valve Replacement.

What interventions are being tested in trial NCT03002272?

The interventions under investigation include: TAVR (DEVICE), SAVR (DEVICE).

Who is sponsoring clinical trial NCT03002272?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03002272 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Replacement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03002272, the US trial registry maintained by the National Library of Medicine. NCT03002272 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.